liarozole has been researched along with Xeroderma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boegheim, JP; Heremans, AM; Lucker, GP; Steijlen, PP; Vanhoutte, FP; Verfaille, CJ | 1 |
| Blanchet-Bardon, C; Steijlen, PM; van Steensel, MA; Vanhoutte, FP; Verfaille, CJ | 1 |
| van Steensel, MA | 1 |
| Boegheim, PJ; Heremans, AM; Lucker, GP; Steijlen, PM; van de Kerkhof, PC | 1 |
1 review(s) available for liarozole and Xeroderma
| Article | Year |
|---|---|
Emerging drugs for ichthyosis.
Topics: Animals; Drug Design; Humans; Ichthyosis; Imidazoles; Keratolytic Agents; Molecular Structure; Tretinoin | 2007 |
3 trial(s) available for liarozole and Xeroderma
| Article | Year |
|---|---|
Topical liarozole in ichthyosis: a double-blind, left-right comparative study followed by a long-term open maintenance study.
Topics: Administration, Cutaneous; Adult; Dermatologic Agents; Double-Blind Method; Humans; Ichthyosis; Imidazoles | 2005 |
Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II/III multicentre, double-blind, randomized, active-controlled study.
Topics: Acitretin; Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Aged; Dermatologic Agents; Double-Blind Method; Female; Humans; Ichthyosis; Imidazoles; Keratolytic Agents; Male; Middle Aged; Treatment Outcome | 2007 |
Oral treatment of ichthyosis by the cytochrome P-450 inhibitor liarozole.
Topics: Adolescent; Adult; Aged; Androgen Antagonists; Cytochrome P-450 Enzyme Inhibitors; Follow-Up Studies; Humans; Ichthyosis; Imidazoles; Keratins; Male; Middle Aged; Prospective Studies; Severity of Illness Index | 1997 |